Sign In
Buy ICCC
$4.91
-0.490 (-9.07%)
At Close: Nov 17, 2025
ImmuCell Corporation (ICCC) Q3 2025 Earnings Call Transcript
11:01am, Friday, 14'th Nov 2025
ImmuCell Corporation ( ICCC ) Q3 2025 Earnings Call November 14, 2025 9:00 AM EST Company Participants Michael Brigham - Special Advisor to the CEO & Director P. F. Te Boekhorst - President, CEO & Dir
ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2025
04:05pm, Thursday, 13'th Nov 2025
PORTLAND, Maine, Nov. 13, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets s
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2025
04:05pm, Thursday, 06'th Nov 2025
PORTLAND, Maine, Nov. 06, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets s
ImmuCell Announces Onboarding of New CEO and Related Management Changes
04:05pm, Tuesday, 04'th Nov 2025
PORTLAND, Maine, Nov. 04, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets s
ImmuCell Announces Preliminary, Unaudited Sales Results for Q3 of 2025
04:05pm, Tuesday, 07'th Oct 2025
PORTLAND, Maine, Oct. 07, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets s
ImmuCell Announces Selection of its Next President and CEO
04:05pm, Monday, 29'th Sep 2025
PORTLAND, Maine, Sept. 29, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets
ImmuCell Swings to Q2 Profit on Strong Sales, Shares Still Slide
11:51am, Thursday, 21'st Aug 2025
ICCC posts Q2 profit on higher sales and margins, but shares fall as investors weigh one-time boosts and Re-Tain's delayed commercialization.
ImmuCell Corporation (ICCC) Q2 2025 Earnings Call Transcript
11:04am, Friday, 15'th Aug 2025
ImmuCell Corporation (NASDAQ:ICCC ) Q2 2025 Earnings Conference Call August 15, 2025 9:00 AM ET Company Participants Michael F. Brigham - President, CEO, Treasurer, Secretary & Director Timothy C.
ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2025
04:05pm, Thursday, 14'th Aug 2025
PORTLAND, Maine, Aug. 14, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets s
ImmuCell Announces Bank Debt Refinancing
04:05pm, Tuesday, 12'th Aug 2025
PORTLAND, Maine, Aug. 12, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets s
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2025
08:00am, Thursday, 07'th Aug 2025
PORTLAND, Maine, Aug. 07, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets s
ImmuCell Upgraded to Outperform on Sales Surge & FDA Upside
12:56pm, Tuesday, 22'nd Jul 2025
ICCC earns "Outperform" rating with record Q1 sales, margin gains and growth potential tied to Re-Tain's FDA progress and new product formats.
ImmuCell Announces Preliminary, Unaudited Sales Results for Q2 of 2025
08:00am, Wednesday, 09'th Jul 2025
PORTLAND, Maine, July 09, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets s
ImmuCell Embarks on CEO Succession Planning Process
08:00am, Wednesday, 25'th Jun 2025
PORTLAND, Maine, June 25, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets s
ImmuCell to Hold Virtual-Only Annual Meeting of Stockholders
06:30am, Thursday, 05'th Jun 2025
PORTLAND, Maine, June 05, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets s
